U.S. Markets close in 5 hrs 57 mins

Novartis’s Innovative Medicines Segment in Q2 2018

Mike Benson
Novartis’s Innovative Medicines Segment in Q2 2018

Novartis’s (NVS) Innovative Medicines segment includes prescription products from two business units: Novartis Pharmaceuticals and Novartis Oncology. The segment contributed 67.4% of Novartis’s total revenues in the second quarter and reported a 10% growth YoY (year-over-year) at $8.9 billion.